Search results
5 questions facing pharma in 2024
BioPharma Dive via Yahoo Finance· 5 months agoNew drugs for obesity and cancer are the focus of many pharma companies, some of which are also grappling with how to manufacture complex cell and gene...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 1 month agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
5 questions facing emerging biotech in 2024
BioPharma Dive via Yahoo Finance· 5 months agoAn unusual FTC challenge could have implications for startups, while industry watchers gauge whether the sector’s recent momentum will end a lengthy...
